Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs

Nonalcoholic steatohepatitis (NASH) is the most severe manifestation of nonalcoholic fatty liver disease (NAFLD), a common complication of type 2 diabetes, and may lead to cirrhosis and hepatocellular carcinoma. Oxidative stress and liver cell damage are the major triggers of the severe hepatic infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Galatou, Eleftheria, Mourelatou, Elena, Hatziantoniou, Sophia, Vizirianakis, Ioannis S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220192/
https://www.ncbi.nlm.nih.gov/pubmed/35739957
http://dx.doi.org/10.3390/antiox11061060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220192/
https://www.ncbi.nlm.nih.gov/pubmed/35739957
http://dx.doi.org/10.3390/antiox11061060

Ejemplares similares